Lead sponsor
Allon Therapeutics
2 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
2
Trials led
0
Ongoing
457
Total enrollment
65
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 2
1
Phase 2/3
1
Trials by status
Completed
2
Trials led
TrialEligibility highlightPhaseStatusEnrollment
Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear PalsyMMSE ≥15Ph 2/3Completed313
Safety, Tolerability and Efficacy Study to Evaluate Subjects With Mild Cognitive ImpairmentMMSE ≥24Ph 2Completed144